ABSTRACT
INTRODUCTION
ZIKA Virus (ZIKV) was first discovered among the Rhesus monkeys of the Zika forests of Uganda in 1947 [1] . The first human case was reported almost six years later in 1953 in Nigeria [2] . Now the ZIKV infections sweep the entire world with numerous cases reported in the Americas, Africa, Asia-pacific countries, and, even certain 'imported' cases by the travelers and migrants to Europe and Oceania [FIGURE:1] [3-4]. There were enormous concerns on the possible transmission of ZIKV infections during the Rio Olympic and Paralympic games. [5-6] The mode of this infection is vector-borne, through the mosquito Aedes aegypti. The reports on vector competency of another mosquito species for ZIKV are controversial [7] [8] [9] [10] . Sexual transmission of ZIKV is also reported [11] . An interesting case study [12] reports an asymptomatic ZIKV positive male, after the subject transmitted the infection to his female sexual partner, who developed major ZIKV symptoms. In addition, transmission via platelet transfusion [13] is also reported, resulted in monitoring of blood transfusion for ZIGV infections [14] .
ZIKV along with Dengue virus (DENV) and Chikungunya virus (CHIKV) belong to the Flavivirus genus and the Flaviviridae family. This infection among pregnant women would result ('Vertical transmission') in Microcephaly and other brain abnormalities of the neonate [FIGURES:2-3] [15] . In adults, it causes Guillain-Barre Syndrome [16] [17] [18] [19] . Other physiological problems such as Hearing loss in microcephalic infants [20] , Abnormal heart rate and Blood pressure [21] and other cardiac problems [22] also are reported to be possible consequences. Anthony R. Mawson-2016 [23] in their dissident hypothesis, state that higher retinoid concentration in liver could be the cause of the reported ZIKV complications and Guillain-Barré syndrome. They suggest the monitoring and comparison of retinoid levels and expression profiles among the microcephalic and control neonates. Similar view, albeit at genetic level, was expressed by Ashutosh Kumar et al. [24] Interestingly, there are no vaccines or anti-viral therapies announced so far by the WHO and the measures available in our hands are prevention and control strategies on spread of these infections. 
TRENDS ON DETECTION AND DIAGNOSIS:
The ZIKV is reported to be diagnosable in Urine, Saliva, Serum and Semen samples. Nicastri E et al., [28] report the presence of ZIKV RNA in Cerebrospinal fluid (CSF). Presence of ZIKV RNA in tears is also reported in Rodent model [29] . Debora Ferreira Barreto-Vieira et al., [30] with their study report fine ultra-structure of ZIKV [FIGURE:4] . Rémi N Charrel et al., [31] in their extensive review describe various common clinical and molecular diagnostic parameters in different biological fluids utilized worldwide [TABLES:1-2]. As conventional serological diagnostic methods are limited by the crossreactivity among the Flavi viruses, PCR-based methods are usually preferred to them. Xu MY et al., [32] developed an YBR Green based real-time RT-PCR for the detection of ZIKV RNA in cell sample. This technique analyses the replication of ZIKV in different times within the living cells. The lower limit of this method is 1PFU per ml. Jinzhao Song et al., [33] developed a simple, costeffective and accurate method for sample collection and DNA amplification which could selectively identify ZIKV with the sensitivity limit of 5 PFUs. This kit could be very useful in distant areas where no facilities are available. The underlying method combines reversetranscription loop-mediated, isothermal amplification (RT-LAMP) assay with a Point-of -Care (POC) cassette for the detection.
[ FIGURES:5-6]
Another technique combining the LAMP principle and AC susceptometry for the detection of ZIKV oligonucleotides is reported [34] . This method could detect the oligonucleotides as low as 1aM (Attomolar). Calvo EP [35] et al., devised a PCR method with the second-round amplification of RNAs with specific inner primers for the specific detection of each viral RNAs during DENV-CHIKV-ZIKV co infections among febrile patients. The cross-reactivity of DENV sera with ZIKV is also studied using focus reduction neutralization tests (FRNTs) by Lalitha Priyamvada et al.,2016 [36] . The FRNT titres of two acute dengue sera (#33 and #39) and one naïve Flavivirus sera (#21) against ZIKV were measured [FIGURE:7]. With their experiment with ZIKV infecting the human FcγR-bearing monocytic cell line, U937 they suggest that DENV antibodies could also enhance the ZIKV infections. Myrna C. Bonaldo et al., [37] report the isolation of ZIKA viral particles from saliva and urine of the patients from the state of Rio de Janiero, Brazil. The urine and saliva samples from patients were inoculated in Vero cell cultures. RNA isolation and quantification were performed by RT-qPCR. ZIKV was isolated from both saliva and urine samples [ 
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samples to be the tools for the effective diagnosis of ZIKV. Dhiraj Acharya et al., [38] 2016 report an Electrogenerated chemiluminescence (ECL) based method to detect ZIKV from body fluids. In this method, the virus (lower limit is 1PFU in 100μL sample) is trapped between ELC labeled -polystyrene beads (PSBs) and magnetic beads conjugated with virus specific antibodies [FIGURE:10] . 
EVIDENCES FROM GENETIC AND SYSTEM BIOLOGICAL APPROACHES:
The genetic diversity of ZIKV strains from various epidemics is widely reported [39] [40] . Meghan May et al. [41] , using system biological approach, report the specific diversity of O-linked glycome across various ZIGV species. Sang-Im Yun et al [42] . report the complete RNA genome sequence of three genetically distinct ZIKV strains MR-766 (Uganda,1947), P6-740 www.ijpbs.com or www.ijpbsonline.com In addition, G.Piorkowski et al [43] report the complete coding sequences of ZIKV isolated from the place Martinique and named 'ZIKAV strain MRS_OPY_-Martinique_PaRi_2015'. The open reading frame (ORF) was found to comprise three structural proteins (Capsid, Pre-membrane/ Membrane, and Envelope) and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). Using Maximum Likelihood analyses in MEGA6 they suggest that it is of Asian lineage and shares nucleotide similarity with strains isolated from French Polynesia and Brazil. An interesting work by Formijn van Hemert et al [44] report the unique Codon usages within ZIKV, which could translate into various key molecules of viral mechanisms. Another similar work [45] is reported in the context of Microcephaly Meanwhile, construction of bioinformatic tools for the analyses of ZIKV RNA Sequence data [46] and epitope analyses for vaccine development [47] also are reported. Similarly, Dikhit MR et al., [48] using Immuno-Informatics identified various MHC Class 1 -restricted epitopes in Capsid, Envelope and NS proteins of ZIKV, against which, effective vaccine could be developed. Alam et al., [49] used similar approaches and found epitopes in Envelope glycoproteins. In fact, certain monoclonal antibodies (mAbs) against ZIKV Envelope proteins were reported [50] to be effective against various ZIKV strains of African, American and Asian origin. By virtue of cross-reactivity mAbs against DENV Envelope epitope which were isolated from the Dengue patients also found to be protective against ZIKV [51] . This conclusion is in contradiction with earlier [32] evidences, which suggest that DENV mAbs could aggravate ZIKV infections.
In addition, Victor Satler Pylro et al., [52] report the creation of the database 'ZIKV -CDB' for analyzing the small noncoding RNAs (sncRNAs) involved in the pathogenesis of ZIKV.
ON PATHOGENESIS:
Various bioinformatic and experimental studies report the link between ZIKV infections and microcephaly in neonates. Using transcriptomic analysis, Gene ontology, and pathway analyses Alyssa J. Rolfe et al., [53] report that human neural progenitor cells (hNPCs) are the high targets of ZIKV, along with the activation of numerous pro-inflammatory cascades. This result is confirmed by another report [54] with the Puerto Ricon ZIKV stain PRVABC59, suggesting the fetal primary human fetal neural progenitors (hNPs) to be the primary targets during neural infections [FIGURE:11] . In addition, Feiran Zhang et al., [55] with their Gene expression and Bioinformatic approaches on Asian (ZIKV C) , African (ZIKV M) , and DENV strains report the strain-specific influence of important hNPCs pathways. Li H et al., [56] also generated similar results from their study. Another study [57] upon Neuroblastoma (NB) cell lines exposed to the PRVABC59 strain, report that undifferentiated are much susceptible to ZIKV infections than the differentiated neurons. This result explains the major absence of ZIKV complications in adults. In this study, cell lines of male origin such as CRL-2267, CCL-127, CRL-2271 and SMS-KCNR, of female origin such as CRL-2266, and CRL-2149, and terminally differentiated olfactory neuroblastoma cell lines such as T-268 and JFEN were used [FIGURE.12] . Altogether these studies explain the pathogenesis behind the onset and aggravation of Microcaphaly among neonates. 
MODELS TO STUDY PATHOGENESIS:
Efforts to simulate the cellular manifestations of ZIKV infection during pregnancy, the subsequent microcephaly and other pathological conditions, demand the development and utilization of relevant model systems such as suitable cell lines and, importantly, animal models to study these mechanisms. Kelli L. Barr et al [58] in their report suggest various cell lines for the effective analyses of ZIKV and Usutu viruses (USUVs). Meanwhile, Konstantin A. Tsetsarkin et al. [59] reports the development of a full length infectious cDNA clone of ZIKV, for studying viral pathogenesis and vaccine development. In addition, Marco Onorati et al., [60] report the establishment of Neuroepithelial stem cells (NES) for studying the neurotropism and microcephaly during ZIKV infections. Interestingly, Dawn M. Dudley et al., [61] from their current long term follow-up study, utilize and propose Rhesus macaques as model to study the mechanisms of ZIKV infections on human [FIGURE :13]. They suggest that this model could effectively simulate the pregnancy conditions in humans. Another group [62] , in a similar work, report their study upon pregnant pigtail macaques to elucidate the fetal brain lesion followed by ZIKV infections [FIGURES:14-15]. Rossi SL et al, [63] in their Review details the necessity of using In vivo models to understand the mechanisms of ZIKV infections during pregnancy and those of the foetus. This Review also details some studies conducted upon Mice. Similar opinions were expressed in the short communications by Na-Na Zhang et al [64] . In addition, Jonathan J. Miner et al., [29] utilized Rodent model to study the ophthalmic damages result from ZIKV infections. Using various receptor knockout mouse strains, they report that these infections could induce severe damages in the ocular systems and ZIKV RNA could be shed into the tears. In this study, mice mutant for Type 1 interferon receptor were selected and infected with ZIKV strains from French Polynesia and Brazil (termed 'Paraίba 2015') [ FIGURE:16]. This study supports the work of Valentine G et al., [65] which analyzed various literature for the ZIKV induced neural and corneal damages. In addition, Jean-Baptiste Brault et al., [66] used mouse model to discriminate the neurotropism of various Flaviviruses. Chick model [67] also is exploited to study the ZIKV infections during pregnancy in the first trimester, which is not possible in Rodent models. Infections in this model resulted in severe cardiac and neural damages much resembling the clinical conditions in humans. Aldo P et al., [68] from their study with human trophoblast cells, suggest that co-infection with Herpes simplex virus-2 (HSV-2), in addition to ZIKV infections, during the first trimester, could sensitize the placental cells for ZIKV entry. Kellie Ann Jurado et al., [69] in their meticulous study with three distinct ZIKV strains, the prototype Uganda/African strain MR766 from 1947 (ZIKV MR766 ), the FSS13025 Cambodian/Asian isolate from 2010 (ZIKV CAM ), and an Americas-derived virus isolated in 2016, MEX 2-81 (ZIKV MEX ), suggest that placentalspecific macrophages and Hofbauer cells (HBCs) are the permissive entry sites for ZIKV to cross the maternal-foetal barrier. A similar study by Takako Tabata et al., [70] suggest that the compound Duramycin could reduce the placental infection of ZIKV.
www.ijpbs.com or www.ijpbsonline.com In addition, Xu M et al. [79] , from their drug screenings, report various FDA approved drugs such as Emricasan, Niclosamide, to be used as antiviral and Caspase-3 inhibitor compounds. Other FDA approved drugs such as Bortezomib, Mycophenolic acid Daptomycin also reported to be anti-ZIKV compounds [80] . The twoapproved anti -HCV drugs, IDX-184 and MK0608, also are reported to be optimally inhibiting the ZIKVpolymerase [81] .
George Savidis et al., [82] reports that Interferoninducible transmembrane proteins (IFITMs) could block ZIKV replication in earlier stages [FIGURE:19] . IFN-β along with IFN-γ are also reported [83] to be effective ZIKV inhibitors in cell cultures. The nucleoside analogs such as 2'-C-methyladenosine and Sofosbuvir also could effectively block ZIKV induced cell death and relocate pTBK1(phosphorylated TANK binding kinase-1), a mechanism which could significantly abrogate the viral pathogenesis [60] . Matthew T. Aliota et al., [84] reports a unique method to control the ZIKV infections via vectors. In their study, the Ifnar -/-C57BL/6 were mice infected with ZIKV. These mice have abrogated type 1-interferon signaling and are much vulnerable to infections and develop high viremia. They used Wolbachia, a maternally inherited intracellular bacterium and infected it upon the Colombian Ae.aegypti mosquito species (termed '(COL)wMel'). The mosquitoes were then fed on the Ifnar -/-C57BL/6 mice for blood meal. Infection, Vector competency, Dissemination, and Transmission rates were compared between wild type (WT) and Colombian (COL) wMel vectors. The COLwMel subjects exhibited much less competence than the WT subjects. In addition, Govindarajan M et al., [85] reports the usage of colloidal silver nanoparticles (AgNPs) to be used as possible larvicidal agents specifically against the ZIKV vector mosquitoes.
CONCLUSION:
One of the common features among all the countries with ZIKV epidemic, is that they are, for the most part, tropical with high humidity and rain fall. Almost no cases are reported in Europe, unless they are transmitted from travelers. So, the virulent ZIKV mutations are almost climate-dependent. We do have www.ijpbs.com or www.ijpbsonline.com the clue that ZIKV pathogenesis are not unique either, as it mostly resembles that of DENV and its structural biology shares much similarity with other Flavi viruses. So, we are not in a complete blind-zone in this area. And most of the research ventures of developed countries of Europe and North America are focused upon Cancers, Heart diseases, Diabetes and Neurodegenerative diseases. Hence, in addition to CDC and WHO, more immediate international efforts are needed to recognize and work on these rapid epidemics such as that of SARS, DENV, Ebola Virus and, currently, ZIKV, to contain and reduce the global mortality rates.
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